Literature DB >> 25733982

How can we best respect patient autonomy in breast cancer treatment decisions?

Sarah T Hawley1,2, Reshma Jagsi3, Kathryn A Martinez1, Allison W Kurian4.   

Abstract

Helping patients to maximize their autonomy in breast cancer decision-making is an important aspect of patient-centered care. Shared decision-making is a strategy that aims to maximize patient autonomy by integrating the values and preferences of the patient with the biomedical expertise of the physician. Application of this approach in breast cancer decision-making has not been uniform across cancer-specific interventions (e.g., surgery, chemotherapy), and in some circumstances may present challenges to evidence-based care delivery. Increasingly precise estimates of individual patients' risk of recurrence and commensurate predicted benefit from certain therapies hold significant promise in helping patients exercise autonomous decision-making for their breast cancer care, yet will also likely complicate decision-making for certain subgroups of patients.

Entities:  

Keywords:  breast cancer; breast-conserving surgery; chemotherapy; endocrine therapy; genetic testing; mastectomy; patient autonomy; shared decision-making

Year:  2015        PMID: 25733982      PMCID: PMC4342843          DOI: 10.2217/bmt.14.47

Source DB:  PubMed          Journal:  Breast Cancer Manag        ISSN: 1758-1923


  108 in total

1.  Endocrine therapy for breast cancer: assessing an array of women's treatment experiences and perceptions, their perceived self-efficacy and nonadherence.

Authors:  Hans Wouters; Anne M Stiggelbout; Marcel L Bouvy; Gemma A Maatman; Erica C G Van Geffen; Robbert Vree; Johan W Nortier; Liset Van Dijk
Journal:  Clin Breast Cancer       Date:  2014-06-02       Impact factor: 3.225

2.  Adoption of hypofractionated radiation therapy for breast cancer after publication of randomized trials.

Authors:  Reshma Jagsi; Aaron D Falchook; Laura H Hendrix; Heather Curry; Ronald C Chen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-12-01       Impact factor: 7.038

Review 3.  Patient preferences for shared decisions: a systematic review.

Authors:  Betty Chewning; Carma L Bylund; Bupendra Shah; Neeraj K Arora; Jennifer A Gueguen; Gregory Makoul
Journal:  Patient Educ Couns       Date:  2011-04-06

4.  When genomic and standard test results diverge: implications for breast cancer patients' preference for chemotherapy.

Authors:  Noel T Brewer; Alrick S Edwards; Suzanne C O'Neill; Janice P Tzeng; Lisa A Carey; Barbara K Rimer
Journal:  Breast Cancer Res Treat       Date:  2008-09-11       Impact factor: 4.872

5.  Desire for information and involvement in treatment decisions: elderly cancer patients' preferences and their physicians' perceptions.

Authors:  Elena B Elkin; Susie H M Kim; Ephraim S Casper; David W Kissane; Deborah Schrag
Journal:  J Clin Oncol       Date:  2007-11-20       Impact factor: 44.544

6.  International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.

Authors:  Kelly A Metcalfe; Daphna Birenbaum-Carmeli; Jan Lubinski; Jacek Gronwald; Henry Lynch; Pal Moller; Parviz Ghadirian; William D Foulkes; Jan Klijn; Eitan Friedman; Charmaine Kim-Sing; Peter Ainsworth; Barry Rosen; Susan Domchek; Teresa Wagner; Nadine Tung; Siranoush Manoukian; Fergus Couch; Ping Sun; Steven A Narod
Journal:  Int J Cancer       Date:  2008-05-01       Impact factor: 7.396

7.  Adherence to adjuvant hormone therapy in low-income women with breast cancer: the role of provider-patient communication.

Authors:  Yihang Liu; Jennifer L Malin; Allison L Diamant; Amardeep Thind; Rose C Maly
Journal:  Breast Cancer Res Treat       Date:  2012-12-23       Impact factor: 4.872

8.  Can women with early-stage breast cancer make an informed decision for mastectomy?

Authors:  E Dale Collins; Caroline P Moore; Kate F Clay; Stephen A Kearing; Annette M O'Connor; Hilary A Llewellyn-Thomas; Richard J Barth; Karen R Sepucha
Journal:  J Clin Oncol       Date:  2008-12-29       Impact factor: 44.544

9.  The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.

Authors:  Joanne S Haviland; J Roger Owen; John A Dewar; Rajiv K Agrawal; Jane Barrett; Peter J Barrett-Lee; H Jane Dobbs; Penelope Hopwood; Pat A Lawton; Brian J Magee; Judith Mills; Sandra Simmons; Mark A Sydenham; Karen Venables; Judith M Bliss; John R Yarnold
Journal:  Lancet Oncol       Date:  2013-09-19       Impact factor: 41.316

10.  Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007.

Authors:  Allison W Kurian; Daphne Y Lichtensztajn; Theresa H M Keegan; Rita W Leung; Sarah J Shema; Dawn L Hershman; Lawrence H Kushi; Laurel A Habel; Tatjana Kolevska; Bette J Caan; Scarlett L Gomez
Journal:  Breast Cancer Res Treat       Date:  2012-11-09       Impact factor: 4.624

View more
  10 in total

1.  Second Opinions From Medical Oncologists for Early-Stage Breast Cancer: Prevalence, Correlates, and Consequences.

Authors:  Allison W Kurian; Christopher R Friese; Irina Bondarenko; Reshma Jagsi; Yun Li; Ann S Hamilton; Kevin C Ward; Steven J Katz
Journal:  JAMA Oncol       Date:  2017-03-01       Impact factor: 33.006

2.  Shared decision making: relevant concepts and facilitating strategies.

Authors:  Jong-Myon Bae
Journal:  Epidemiol Health       Date:  2017-10-30

3.  Adapting the Breast Cancer Surgery Decision Quality Instrument for Lower Socioeconomic Status: Improving Readability, Acceptability, and Relevance.

Authors:  Marie-Anne Durand; Julia Song; Renata West Yen; Karen Sepucha; Mary C Politi; Shubhada Dhage; Kari Rosenkranz; Julie Margenthaler; Anna N A Tosteson; Eloise Crayton; Sherrill Jackson; Ann Bradley; A James O'Malley; Robert J Volk; Elissa Ozanne; Sanja Percac-Lima; Jocelyn Acosta; Nageen Mir; Peter Scalia; Abigail Ward; Glyn Elwyn
Journal:  MDM Policy Pract       Date:  2018-11-25

4.  Travel, Treatment Choice, and Survival Among Breast Cancer Patients: A Population-Based Analysis.

Authors:  Colleen F Longacre; Hannah T Neprash; Nathan D Shippee; Todd M Tuttle; Beth A Virnig
Journal:  Womens Health Rep (New Rochelle)       Date:  2021-01-11

5.  Cross-sectional nationwide mixed-methods population-based study of living conditions, and identification of sexual and fertility profiles among young women after breast cancer in France: the Candy study protocol.

Authors:  Emerline L F Assogba; Agnès Dumas; Anne-Sophie Woronoff; Caroline Mollévi; Charles Coutant; Sylvain Ladoire; Isabelle Desmoulins; Tienhan Sandrine Dabakuyo-Yonli
Journal:  BMJ Open       Date:  2022-09-28       Impact factor: 3.006

6.  Overview on Patient Centricity in Cancer Care.

Authors:  Šarunas Narbutas; Kristina York; Barry D Stein; Kara Magsanoc-Alikpala; Yoshiyuki Majima; Zoltan Kalo; Timea Almasi; Andras Inotai
Journal:  Front Pharmacol       Date:  2017-10-05       Impact factor: 5.810

7.  Relational autonomy in breast diseases care: a qualitative study of contextual and social conditions of patients' capacity for decision-making.

Authors:  Patti Shih; Frances Rapport; Anne Hogden; Mia Bierbaum; Jeremy Hsu; John Boyages; Jeffrey Braithwaite
Journal:  BMC Health Serv Res       Date:  2018-10-25       Impact factor: 2.655

Review 8.  Stereotactic ablative radiotherapy for oligometastatic breast cancer in elderly patients.

Authors:  Ignacio Morales-Orue; Juan Zafra-Martin; Laura Garcia; Rodolfo Chicas-Sett; Juan Castilla-Martinez; Maria Auxiliadora Cabezon; Javier Burgos; Marta Lloret; Pedro C Lara
Journal:  Transl Cancer Res       Date:  2020-01       Impact factor: 1.241

9.  Study protocol: A Randomized Controlled Trial of a Comprehensive Breast Cancer Treatment Patient Decision Tool (iCanDecide).

Authors:  Sarah T Hawley; Yun Li; L Alexandra Jeanpierre; Stefanie Goodell; Reshma Jagsi; Kevin C Ward; Michael S Sabel; Steven J Katz
Journal:  Contemp Clin Trials Commun       Date:  2017-02-03

10.  How patients experience endocrine therapy for breast cancer: an online survey of side effects, adherence, and medical team support.

Authors:  Maurice J Berkowitz; Carlie K Thompson; Laura T Zibecchi; Minna K Lee; Elani Streja; Jacob S Berkowitz; Cachet M Wenziger; Jennifer L Baker; Maggie L DiNome; Deanna J Attai
Journal:  J Cancer Surviv       Date:  2020-08-17       Impact factor: 4.062

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.